Problem · Life science
Everything we write sits in review for weeks and nothing publishes.
The draft is done. It goes to the scientific founder or the medical director for review. Two weeks later it comes back with comments on word choice, the writer revises, and the cycle repeats. Vodori's 2025 benchmark puts the average review job at 14.8 days from submission to approval; at large pharma Indegene reports 50 to 60. A small company does not need a committee. It needs one reviewer, a claim library, and a log.
How people search thisscientific content review bottleneck · medical review slowing down marketing content · how to speed up mlr review · content approval process biotech · claim library for marketing content
The MLR review gate add on: named reviewer workflow, sign off log, and claim library. $500 a month plus $750 setup on Baseline, $750 plus $1,000 on Catalyst, $1,200 plus $1,500 on Kinetic. You provide the reviewer. Pricing is published.
Why review takes two weeks
The reviewer sees the whole draft, so they review the prose, and you get comments on adjectives that take two more cycles. The same reference gets checked for the fourth time because nobody recorded that it was approved in March. The claim gets rewritten mid cycle. And the reviewer is a physician or a PI with a day job, reading your draft on a Sunday. None of that is the reviewer's fault. It is a workflow that routes whole documents to a busy expert.
The weekly workflow
Build the claim library first: every clinical, safety, efficacy, or performance statement the company is allowed to make, each with its reference, approved once. Write from the library, so 80 percent of a post is already approved language. Flag only the new claims, attach the reference, and send one batch a week. Monday drafts go out, Wednesday comments return, Thursday revisions, Friday publish. Log the reviewer's name, the date, and the version. One reviewer hour a week supports a newsletter, a post, and a month of social.
Content that does not touch a claim, a founder story, a hiring post, a conference recap, a photo of the lab, skips the gate entirely. That is most of it, which is why a regulated company can still publish eight or sixteen posts a month.
What a CRO or tools company actually needs to gate
Not the pharma version. Methods, turnaround, and specifications do not need a medical reviewer. Any claim about preclinical efficacy, a translational outcome, or a clinical result does. Most CRO content skips the gate, and the gate exists so the pieces that need it move in a week instead of a quarter.
Questions on this problem
You name one with an MD or PhD credential who is accountable to you: a medical director, a scientific founder, or a contracted reviewer. We build the workflow around that person and do not supply one, on purpose.
Only the ones that make a clinical, safety, or efficacy claim. Batch those into the weekly review with the blog post. The rest publishes on schedule.
Building the claim library from your existing approved materials: papers, validated specs, prior approved content. That is the setup fee, and it is also what you hand a new agency or hire on day one.
George Stoff, Founder and Lead Engineer
Thirty years building software, brands, and demand. On every account.